Population
Experimental animal models (murine brain renin-angiotensin system)
Comparison
Intracerebroventricular injection of… vs Intravenous injection, exogenous AngII alone, or…
Design
Preclinical
Authors
Loading...
May inform central APA inhibitor development in hypertension models; leaves open human translation of brain AngIII targeting.
Angiotensin III is identified as a major effector peptide of the brain renin-angiotensin system, suggesting aminopeptidase A inhibitors could serve as central anti-hypertensive agents.
Iturrioz et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: